In this report, the EMEA Intravenous Immunoglobulin (IVIg) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Intravenous Immunoglobulin (IVIg) for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Intravenous Immunoglobulin (IVIg) market competition by top manufacturers/players, with Intravenous Immunoglobulin (IVIg) sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
CSL Behring
Grifols
Octapharma
Shire
ADMA Biologics
Bayer
Bharat Serum and Vaccines
Biotest
China Biologic Products
Hualan Biological Engineering
Kedrion Biopharma
Sanquin
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Neurology
Hematology
Immunology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Immunology
Oncology
Pulmonology
Rheumatology
Transplant
Neurology
Hematology
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Intravenous Immunoglobulin (IVIg) Market Report 2017
1 Intravenous Immunoglobulin (IVIg) Overview
1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg)
1.2 Classification of Intravenous Immunoglobulin (IVIg)
1.2.1 EMEA Intravenous Immunoglobulin (IVIg) Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Intravenous Immunoglobulin (IVIg) Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Neurology
1.2.4 Hematology
1.2.5 Immunology
1.3 EMEA Intravenous Immunoglobulin (IVIg) Market by Application/End Users
1.3.1 EMEA Intravenous Immunoglobulin (IVIg) Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Immunology
1.3.3 Oncology
1.3.4 Pulmonology
1.3.5 Rheumatology
1.3.6 Transplant
1.3.7 Neurology
1.3.8 Hematology
1.3.9 Others
1.4 EMEA Intravenous Immunoglobulin (IVIg) Market by Region
1.4.1 EMEA Intravenous Immunoglobulin (IVIg) Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Intravenous Immunoglobulin (IVIg) (2012-2022)
1.5.1 EMEA Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2022)
1.5.2 EMEA Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2022)
2 EMEA Intravenous Immunoglobulin (IVIg) Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Intravenous Immunoglobulin (IVIg) Market Competition by Players/Manufacturers
2.1.1 EMEA Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Intravenous Immunoglobulin (IVIg) Revenue and Share by Players (2012-2017)
2.1.3 EMEA Intravenous Immunoglobulin (IVIg) Sale Price by Players (2012-2017)
2.2 EMEA Intravenous Immunoglobulin (IVIg) (Volume and Value) by Type/Product Category
2.2.1 EMEA Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Intravenous Immunoglobulin (IVIg) Sale Price by Type (2012-2017)
2.3 EMEA Intravenous Immunoglobulin (IVIg) (Volume) by Application
2.4 EMEA Intravenous Immunoglobulin (IVIg) (Volume and Value) by Region
2.4.1 EMEA Intravenous Immunoglobulin (IVIg) Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Intravenous Immunoglobulin (IVIg) Sales Price by Region (2012-2017)
3 Europe Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
3.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
3.2 Europe Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
3.3 Europe Intravenous Immunoglobulin (IVIg) Sales and Market Share by Application
3.4 Europe Intravenous Immunoglobulin (IVIg) Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales Volume by Countries (2012-2017)
3.4.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
3.4.3 Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
3.4.4 France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
3.4.5 UK Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
3.4.6 Russia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
3.4.7 Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
3.4.8 Benelux Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
4 Middle East Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
4.1.1 Middle East Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
4.2 Middle East Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
4.3 Middle East Intravenous Immunoglobulin (IVIg) Sales and Market Share by Application
4.4 Middle East Intravenous Immunoglobulin (IVIg) Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Intravenous Immunoglobulin (IVIg) Sales Volume by Countries (2012-2017)
4.4.2 Middle East Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
4.4.4 Israel Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
4.4.5 UAE Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
4.4.6 Iran Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
5 Africa Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
5.1.1 Africa Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
5.2 Africa Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
5.3 Africa Intravenous Immunoglobulin (IVIg) Sales and Market Share by Application
5.4 Africa Intravenous Immunoglobulin (IVIg) Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Intravenous Immunoglobulin (IVIg) Sales Volume by Countries (2012-2017)
5.4.2 Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries (2012-2017)
5.4.3 South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
5.4.5 Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
5.4.6 Algeria Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2017)
6 EMEA Intravenous Immunoglobulin (IVIg) Manufacturers/Players Profiles and Sales Data
6.1 CSL Behring
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 CSL Behring Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Grifols
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Octapharma
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Shire
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Shire Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 ADMA Biologics
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bayer
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bayer Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Bharat Serum and Vaccines
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Biotest
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 China Biologic Products
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 China Biologic Products Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Hualan Biological Engineering
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Intravenous Immunoglobulin (IVIg) Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Kedrion Biopharma
6.12 Sanquin
7 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
7.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Intravenous Immunoglobulin (IVIg) Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Intravenous Immunoglobulin (IVIg) Market Forecast (2017-2022)
11.1 EMEA Intravenous Immunoglobulin (IVIg) Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Intravenous Immunoglobulin (IVIg) Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Intravenous Immunoglobulin (IVIg) Price and Trend Forecast (2017-2022)
11.2 EMEA Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2017-2022)
11.7 EMEA Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Intravenous Immunoglobulin (IVIg)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Volume Market Share by Type (Product Category) in 2016
Figure Neurology Product Picture
Figure Hematology Product Picture
Figure Immunology Product Picture
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application in 2016
Figure Immunology Examples
Table Key Downstream Customer in Immunology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Pulmonology Examples
Table Key Downstream Customer in Pulmonology
Figure Rheumatology Examples
Table Key Downstream Customer in Rheumatology
Figure Transplant Examples
Table Key Downstream Customer in Transplant
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Hematology Examples
Table Key Downstream Customer in Hematology
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Intravenous Immunoglobulin (IVIg) Market Size (Million USD) by Region (2012-2022)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Status and Forecast by Countries
Figure Africa Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2022)
Figure EMEA Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Intravenous Immunoglobulin (IVIg) Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Share by Players (2012-2017)
Figure 2016 Intravenous Immunoglobulin (IVIg) Sales Share by Players
Figure 2017 Intravenous Immunoglobulin (IVIg) Sales Share by Players
Figure EMEA Intravenous Immunoglobulin (IVIg) Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue (Million USD) by Players (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue Share by Players (2012-2017)
Table 2016 EMEA Intravenous Immunoglobulin (IVIg) Revenue Share by Players
Table 2017 EMEA Intravenous Immunoglobulin (IVIg) Revenue Share by Players
Table EMEA Intravenous Immunoglobulin (IVIg) Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Share by Type (2012-2017)
Figure Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type (2012-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Type in 2016
Table EMEA Intravenous Immunoglobulin (IVIg) Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Share by Application (2012-2017)
Figure Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application (2012-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2016
Table EMEA Intravenous Immunoglobulin (IVIg) Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Share by Region (2012-2017)
Figure Sales Market Share of Intravenous Immunoglobulin (IVIg) by Region (2012-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share in 2016
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Region (2012-2017)
Figure EMEA Intravenous Immunoglobulin (IVIg) Revenue Market Share Regions in 2016
Table EMEA Intravenous Immunoglobulin (IVIg) Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Market Share by Type (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Market Share by Type in 2016
Table Europe Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Market Share by Application (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Market Share by Application in 2016
Table Europe Intravenous Immunoglobulin (IVIg) Sales (K MT) by Countries (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2016
Table Europe Intravenous Immunoglobulin (IVIg) Revenue (Million USD) by Countries (2012-2017)
Table Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2016
Figure Germany Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure France Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure UK Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Market Share by Type (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Market Share by Type (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales (K MT) by Applications (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Market Share by Applications (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2016
Table Middle East Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales Volume Market Share by Countries in 2016
Table Middle East Intravenous Immunoglobulin (IVIg) Revenue (Million USD) by Countries (2012-2017)
Table Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2016
Figure Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2012-2017)
Table Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2016
Table Africa Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application (2012-2017)
Table Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
Table Africa Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) by Countries (2012-2017)
Table Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2016
Table Africa Intravenous Immunoglobulin (IVIg) Revenue (Million USD) by Countries (2012-2017)
Table Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2012-2017)
Figure Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2016
Figure South Africa Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Table CSL Behring Intravenous Immunoglobulin (IVIg) Basic Information List
Table CSL Behring Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure CSL Behring Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure CSL Behring Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure CSL Behring Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table Grifols Intravenous Immunoglobulin (IVIg) Basic Information List
Table Grifols Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Grifols Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Grifols Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure Grifols Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table Octapharma Intravenous Immunoglobulin (IVIg) Basic Information List
Table Octapharma Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Octapharma Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Octapharma Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure Octapharma Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table Shire Intravenous Immunoglobulin (IVIg) Basic Information List
Table Shire Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Shire Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Shire Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure Shire Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table ADMA Biologics Intravenous Immunoglobulin (IVIg) Basic Information List
Table ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure ADMA Biologics Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table Bayer Intravenous Immunoglobulin (IVIg) Basic Information List
Table Bayer Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Bayer Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure Bayer Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Basic Information List
Table Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table Biotest Intravenous Immunoglobulin (IVIg) Basic Information List
Table Biotest Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biotest Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Biotest Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure Biotest Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table China Biologic Products Intravenous Immunoglobulin (IVIg) Basic Information List
Table China Biologic Products Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure China Biologic Products Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure China Biologic Products Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure China Biologic Products Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Basic Information List
Table Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2017)
Figure Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales Market Share in EMEA (2012-2017)
Figure Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Revenue Market Share in EMEA (2012-2017)
Table Kedrion Biopharma Intravenous Immunoglobulin (IVIg) Basic Information List
Table Sanquin Intravenous Immunoglobulin (IVIg) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
Table Raw Materials Sources of Intravenous Immunoglobulin (IVIg) Major Manufacturers in 2016
Table Major Buyers of Intravenous Immunoglobulin (IVIg)
Table Distributors/Traders List
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Intravenous Immunoglobulin (IVIg) Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2017-2022)
Table EMEA Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2017-2022)
Table Europe Intravenous Immunoglobulin (IVIg) Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Countries (2017-2022)
Table Europe Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Intravenous Immunoglobulin (IVIg) Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Intravenous Immunoglobulin (IVIg) Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Countries (2017-2022)
Table Africa Intravenous Immunoglobulin (IVIg) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2017-2022)
Table EMEA Intravenous Immunoglobulin (IVIg) Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
